Press Resease

Small Molecule Targeted Cancer Therapy Market - Global Industry Analysis

Small Molecule Targeted Cancer Therapy Market by Type (Small Molecule Drug Conjugates, Small Molecules and Monoclonal Antibodies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Published Date: 17-Feb-2020 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-5253 Status : Published

Description

The report covers forecast and analysis for the small molecule targeted cancer therapy market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the small molecule targeted cancer therapy market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the small molecule targeted cancer therapy market on a global as well as regional level.

In order to give the users of this report a comprehensive view on the small molecule targeted cancer therapy market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness.

Global Small Molecule Targeted Cancer Therapy Market

The report provides company market share analysis in order to give a broader overview of the key players in the small molecule targeted cancer therapy market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new type launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the small molecule targeted cancer therapy market on global and regional basis.

The study provides a crucial view on the small molecule targeted cancer therapy by segmenting the market based on type, and region. All the segments of small molecule targeted cancer therapy market have been analyzed based on present and future trends and the market is estimated from 2018 to 2025.

Targeted cancer therapy uses drugs that specifically target cancer specific proteins, genes, tissue environment that assists in cancer cells’ growth and survival. These proteins or genes found in cancerous cells or blood vessel cells that are related to cancer growth. Targeted therapy uses signal transduction inhibitors, hormone therapies, angiogenesis inhibitors, apoptosis inducers, gene expression modulators, immunotherapies, monoclonal antibodies etc. Small molecule targeted therapy generally uses molecules of ≤5000 Da and are administered via oral route. Due to the small size, these molecules can easily translocate through the plasma membrane and can interact with intracellular signaling molecules and cell-surface receptors’ cytoplasmic domain.

The demand for small molecule targeted cancer therapy market is driven by growing preference for cancer therapies with minimal adverse events, increasing cancer prevalence and increasing awareness. Additionally, growing adoption of targeted therapy over chemotherapy, increasing health spending and disposable are important factors that boost the market growth. However, slower drug approval process, stringent regulatory requirements and high operational cost may limit the market growth over the forecast period. Patent expiry of major drugs is expected to bring growth opportunities over the forecast period for global small molecule targeted cancer therapy market.

Based on type, global small molecule targeted cancer therapy market is segmented into small molecule drug conjugates, small molecules and monoclonal antibodies. Small molecules type segment accounted for largest market share in 2018 due to its effectiveness and lesser side effects. Small molecules type segment is sub segmented into small molecule tyrosine kinase inhibitor, proteasome inhibitor and small molecule cyclin-dependent kinase inhibitor. Monoclonal antibodies segment is further split into humanized monoclonal antibody, chimeric monoclonal antibody and fully human antibody. Thus upper eyelid surgeries are most common and accounted for largest market share. Small molecule drug conjugates segment is projected to witness highest growth over the forecast period.

North America dominated the global small molecule targeted cancer therapy market in 2018. Increasing cancer prevalence, favorable reimbursement policies, presence of advanced health facilities, increasing health spending and increasing preference for therapies with minimal side effects are factors driving the market in this region. Europe was second largest regional small molecule targeted cancer therapy market. Growing awareness about cancer and advanced therapies, faster adoption of novel therapies are major factors that boost market growth in this region. Latin America is projected to exhibit moderate growth over the forecast period. Asia Pacific region will register highest CAGR for small molecule targeted cancer therapy market during the forecast period. Large population base, increasing cancer prevalence, growth in demand for targeted therapy with lesser side effects than chemotherapy, government initiatives to create awareness and increasing healthcare spending are factors promoting small molecule targeted cancer therapy market growth in Asia Pacific. Middle East and Africa region is estimated to show slower growth in coming years.

Major players included in the report are Abbott Laboratories, Bayer HealthCare AG, Boehringer Ingelheim GmbH, GlaxoSmithKline plc, Hospira Inc., Cytokinetics Inc. and OncoGenex Pharmaceuticals, Inc. among others.

The report segment of global small molecule targeted cancer therapy market as follows:

Global Small Molecule Targeted Cancer Therapy Market: By Type

  • Monoclonal Antibodies
    • Fully Human Antibody
    • Chimeric Monoclonal Antibody
    • Humanized Monoclonal Antibody
  • Small Molecules
    • Small Molecule Cyclin-dependent Kinase Inhibitor
    • Small Molecule Proteasome Inhibitor
    • Small Molecule Tyrosine Kinase Inhibitor
  • Small Molecule Drug Conjugates

Global Small Molecule Targeted Cancer Therapy Market: By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Small Mulecule Targeted Cancer Therapy Market, 2016 - 2025, (USD Million)
    • 2.2. Small Mulecule Targeted Cancer Therapy Market: Snapshot
  • Chapter 3. Global Small Mulecule Targeted Cancer Therapy Market – Industry Analysis
    • 3.1. Small Mulecule Targeted Cancer Therapy Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Growing Demand for Targeted Therapy with Lesser Side Effects over Chemotherapy
      • 3.2.2. Increasing Cancer Prevalence
    • 3.3. Restraints
      • 3.3.1. Longer Drug Approval Time and Stringent Regulatory Requirements
    • 3.4. Opportunity
      • 3.4.1. Patent Expiry of Major Drugs
    • 3.5. Porter’s Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by type segment
      • 3.6.2. Market attractiveness analysis by regional segment
  • Chapter 4. Global Small Mulecule Targeted Cancer Therapy Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global small mulecule targeted cancer therapy market: company market share analysis, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New type launches
      • 4.2.3. Agreements, partnerships, cullaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global Small Mulecule Targeted Cancer Therapy Market – Type Segment Analysis
    • 5.1. Global small mulecule targeted cancer therapy market overview: by type
      • 5.1.1. Global small mulecule targeted cancer therapy market revenue share, by type, 2018 and 2025
    • 5.2. Monoclonal Antibodies
      • 5.2.1. Global small mulecule targeted cancer therapy market by Monoclonal Antibodies, 2016-2025 (USD Million)
    • 5.3. Small Mulecules
      • 5.3.1. Global small mulecule targeted cancer therapy market by Small Mulecules, 2016-2025 (USD Million)
    • 5.4. Small Mulecule Drug Conjugates
      • 5.4.1. Global small mulecule targeted cancer therapy market by Small Mulecule Drug Conjugates, 2016-2025 (USD Million)
  • Chapter 6. Global Small Mulecule Targeted Cancer Therapy Market - Regional Analysis
    • 6.1. Global small mulecule targeted cancer therapy market overview: by region
      • 6.1.1. Global small mulecule targeted cancer therapy market revenue share, by region, 2018 and 2025
    • 6.2. North America
      • 6.2.1. North America small mulecule targeted cancer therapy market, by country, 2016-2025 (USD Million)
      • 6.2.2. North America small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
      • 6.2.3. The U.S.
        • 6.2.3.1. The U.S. small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
      • 6.2.4. Rest of North America
        • 6.2.4.1. Rest of North America small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
    • 6.3. Europe
      • 6.3.1. Europe small mulecule targeted cancer therapy market, by country, 2016-2025 (USD Million)
      • 6.3.2. Europe small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
      • 6.3.3. U.K.
        • 6.3.3.1. U.K. small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
      • 6.3.4. France
        • 6.3.4.1. France small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
      • 6.3.5. Germany
        • 6.3.5.1. Germany small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
      • 6.3.6. Rest of Europe
        • 6.3.6.1. Rest of Europe small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific small mulecule targeted cancer therapy market, by country, 2016-2025 (USD Million)
      • 6.4.2. Asia Pacific small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
      • 6.4.3. China
        • 6.4.3.1. China small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
      • 6.4.4. Japan
        • 6.4.4.1. Japan small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
      • 6.4.5. India
        • 6.4.5.1. India small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
      • 6.4.6. Rest of Asia Pacific
        • 6.4.6.1. Rest of Asia Pacific small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
    • 6.5. Latin America
      • 6.5.1. Latin America small mulecule targeted cancer therapy market, by country, 2016-2025 (USD Million)
      • 6.5.2. Latin America small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
      • 6.5.3. Brazil
        • 6.5.3.1. Brazil small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
      • 6.5.4. Rest of Latin America
        • 6.5.4.1. Rest of Latin America small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
    • 6.6. Middle East & Africa
      • 6.6.1. Middle East & Africa small mulecule targeted cancer therapy market, 2016-2025 (USD Million)
      • 6.6.2. Middle East & Africa small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
  • Chapter 7. Company Profiles
    • 7.1. Abbott Laboratories
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Type Portfolio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Boehringer Ingelheim GmbH
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Type Portfolio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. Bayer HealthCare AG
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Type Portfolio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Developments
    • 7.4. GlaxoSmithKline plc
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Type Portfolio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Developments
    • 7.5. Hospira Inc.
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Type Portfolio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Developments
    • 7.6. Cytokinetics Inc.
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Type Portfolio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Developments
    • 7.7. OncoGenex Pharmaceuticals, Inc.
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Type Portfolio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Developments

List of Figures

1. Market research process
2. Market research methodology
3. Global small molecule targeted cancer therapy market, 2016-2025 (USD Million)
4. Porter’s five forces analysis: small molecule targeted cancer therapy market
5. Global small molecule targeted cancer therapy market attractiveness, by type
6. Global small molecule targeted cancer therapy market revenue share, by type, 2018 and 2025
7. Global small molecule targeted cancer therapy market by monoclonal antibodies, 2016-2025 (USD Million)
8. Global small molecule targeted cancer therapy market by small molecules, 2016-2025 (USD Million)
9. Global small molecule targeted cancer therapy market by small molecule drug conjugates, 2016-2025 (USD Million)
10. Global small molecule targeted cancer therapy market revenue share, by region, 2018 & 2025
11. North America small molecule targeted cancer therapy market, 2016-2025 (USD Million)
12. Europe small molecule targeted cancer therapy market, 2016-2025 (USD Million)
13. Asia Pacific small molecule targeted cancer therapy market, 2016-2025 (USD Million)
14. Latin America small molecule targeted cancer therapy market, 2016-2025 (USD Million)
15. Middle East & Africa small molecule targeted cancer therapy market, 2016-2025 (USD Million)
 


List of Tables

1. Global small molecule targeted cancer therapy market: snapshot
2. Drivers for small molecule targeted cancer therapy market: impact analysis
3. Restraints for small molecule targeted cancer therapy market: impact analysis
4. North America small molecule targeted cancer therapy market revenue, by country, 2016-2025 (USD Million)
5. North America small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
6. North America small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
7. North America small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
8. The U.S. small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
9. The U.S. small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
10. The U.S. small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
11. Rest of North America small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
12. Rest of North America small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
13. Rest of North America small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
14. Europe small molecule targeted cancer therapy market revenue, by country, 2016-2025 (USD Million)
15. Europe small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
16. Europe small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
17. Europe small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
18. U.K. small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
19. U.K. small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
20. U.K. small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
21. France small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
22. France small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
23. France small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
24. Germany small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
25. Germany small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
26. Germany small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
27. Rest of Europe small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
28. Rest of Europe small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
29. Rest of Europe small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
30. Asia Pacific small molecule targeted cancer therapy market revenue, by country, 2016-2025 (USD Million)
31. Asia Pacific small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
32. Asia Pacific small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
33. Asia Pacific small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
34. China small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
35. China small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
36. China small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
37. Japan small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
38. Japan small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
39. Japan small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
40. India small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
41. India small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
42. India small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
43. Rest of Asia Pacific small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
44. Rest of Asia Pacific small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
45. Rest of Asia Pacific small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
46. Latin America small molecule targeted cancer therapy market revenue, by country, 2016-2025 (USD Million)
47. Latin America small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
48. Latin America small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
49. Latin America small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
50. Brazil small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
51. Brazil small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
52. Brazil small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
53. Rest of Latin America small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
54. Rest of Latin America small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
55. Rest of Latin America small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
56. Middle  East & Africa small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
57. Middle  East & Africa small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
58. Middle  East & Africa small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social